3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol
- $45 - $904
- Product name: 3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol
- CAS: 1171919-89-3
- MF: C10H11NO3
- MW: 193.2
- EINECS:
- MDL Number:MFCD12401638
- Synonyms:3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol;2-Propyn-1-ol, 3-(5,6-dimethoxy-3-pyridinyl)-
5 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
- TRC
Package
- 10mg
- 100mg
- 250mg
- 1g
- ManufacturerAK Scientific
- Product number9848AC
- Product description3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol
- Packaging250mg
- Price$511
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11341790
- Product description3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol 95+%
- Packaging1g
- Price$904
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number048376
- Product description3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol
- Packaging250mg
- Price$342
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD525890
- Product description3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD525890
- Product description3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol
- Packaging100mg
- Price$240
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 9848AC | 3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol | 250mg | $511 | 2021-12-16 | Buy |
Crysdot | CD11341790 | 3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol 95+% | 1g | $904 | 2021-12-16 | Buy |
Matrix Scientific | 048376 | 3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol | 250mg | $342 | 2021-12-16 | Buy |
TRC | D525890 | 3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol | 10mg | $45 | 2021-12-16 | Buy |
TRC | D525890 | 3-(5,6-Dimethoxypyridin-3-yl)prop-2-yn-1-ol | 100mg | $240 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|